EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The transcriptome of CD14 + CD163 − HLA-DR low monocytes predicts mortality in idiopathic pulmonary fibrosis

Theodoros Karampitsakos, Minxue Jia iD, Bochra Tourki, Zainab Fatima, Bogdan Visinescu, Carole Y Perrot, Tamer Fadli, Amy Zhao, Avraham Unterman iD, Marc A Schneider iD, Debabrata Bandyopadhyay iD, Brenda M Juan-Guardela und 12 weitere

European Respiratory Journal · 2026

DOI: 10.1183/13993003.00804-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Theodoros Karampitsakos und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani Colle…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Monocytes, Transcriptome, HLA-DR Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, USF Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between immune-cell-specific transcriptomic profiles and mortality in idiopathic pulmonary fibrosis (IPF) is unknown.

Methods

We profiled peripheral blood mononuclear cells by single-cell RNA sequencing (scRNA-seq) and investigated which immune-cell-specific transcriptomic profile predicted IPF outcomes consistently. Prognostic accuracy was investigated in peripheral blood mononuclear cells (PBMCs), bronchoalveolar lavage (BAL) and lung tissue. Findings were validated by flow cytometry, analysis of independent scRNA-seq datasets and cellular deconvolution. We investigated the function of this transcriptomic profile and its cellular source in lung tissue (overall sample size, n=1054; IPF, n=555; other, n=499). Connectivity map analysis and LASSO regression were used to identify drug candidates and a subset of genes with prognostic potential, respectively.

Results

A 230-gene up-score (Pittsburgh PBMC cohort) from CD14 + CD163 − HLA-DR low monocytes predicted mortality in the Chicago PBMC cohort (HR 6.58, 95% CI 2.15–20.13; p=0.001), in BAL pooled analysis (HR 2.20, 95% CI 1.44–3.37; p=0.0003), and negatively correlated with forced vital capacity in lung tissues (ρ= −0.2, p=0.02). Proportions of CD14 + CD163 − HLA-DR low monocytes were higher in progressive versus stable IPF (12.59%, 95% CI 9.66–16.23%, versus 7.61%, 95% CI 6.68–10.21%; p=0.014). High-risk patients with IPF had decreased expression of T-cell co-stimulatory genes (Pittsburgh and Chicago, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisMonocytesTranscriptomeHLA-DR AntigensHumansMaleFemaleAgedMiddle AgedLipopolysaccharide ReceptorsPrognosisLeukocytes, MononuclearCD163 AntigenAntigens, CDLungReceptors, Cell SurfaceBronchoalveolar Lavage FluidGene Expression ProfilingSingle-Cell Analysis

Substanzen

Lipopolysaccharide ReceptorsHLA-DR AntigensCD163 AntigenAntigens, CDReceptors, Cell SurfaceCD14 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • These authors contributed equally to this work.
  • Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Associates in Discipline, Columbia Engineering, Artificial Intelligence Program, Columbia University, New York, NY, USA.
  • Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.

ORCID-Profile: Minxue Jia, Avraham Unterman, Marc A Schneider, Debabrata Bandyopadhyay, Antje Prasse, Naftali Kaminski, Panayiotis V Benos, Jose D Herazo-Maya

Förderung

  • NHLBI NIH HHS
  • USF Foundation
  • National Institutes of Health

Zitieren

APA

Karampitsakos, T., Jia, M., Tourki, B., Fatima, Z., Visinescu, B., Perrot, C. Y., Fadli, T., Zhao, A., Unterman, A., Schneider, M. A., Bandyopadhyay, D., Juan-Guardela, B. M., Vamvakaris, I., Prasse, A., Noth, I., Liggett, S., Kreuter, M., Drake, W., Tzouvelekis, A., …, & Herazo-Maya, J. D. (2026). The transcriptome of CD14 + CD163 − HLA-DR low monocytes predicts mortality in idiopathic pulmonary fibrosis. European Respiratory Journal. https://doi.org/10.1183/13993003.00804-2025

Vancouver

Karampitsakos T, Jia M, Tourki B, Fatima Z, Visinescu B, Perrot CY, et al. The transcriptome of CD14 + CD163 − HLA-DR low monocytes predicts mortality in idiopathic pulmonary fibrosis. European Respiratory Journal. 2026. doi:10.1183/13993003.00804-2025

BibTeX
@article{Karampitsakos2026,
  author = {Karampitsakos, Theodoros and Jia, Minxue and Tourki, Bochra and Fatima, Zainab and Visinescu, Bogdan and Perrot, Carole Y and Fadli, Tamer and Zhao, Amy and Unterman, Avraham and Schneider, Marc A and Bandyopadhyay, Debabrata and Juan-Guardela, Brenda M and Vamvakaris, Ioannis and Prasse, Antje and Noth, Imre and Liggett, Stephen and Kreuter, Michael and Drake, Wonder and Tzouvelekis, Argyris and Garcia, Joe G N and Herzog, Erica and Kaminski, Naftali and Benos, Panayiotis V and Herazo-Maya, Jose D},
  title = {The transcriptome of CD14 + CD163 − HLA-DR low monocytes predicts mortality in idiopathic pulmonary fibrosis},
  journal = {European Respiratory Journal},
  year = {2026},
  doi = {10.1183/13993003.00804-2025}
}
Kostenlos starten →